$102.80
-2.21-2.10%
At Close: -
$102.80
00.00%
After Hours: Sep 20, 4:04 PM EDT
15 minutes delayed
Comments
Loading...
Ligand Pharmaceuticals (NASDAQ:LGND) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Ligand Pharmaceuticals (LGND)?
The most recent guidance for Ligand Pharmaceuticals (LGND) was reported on August 6, 2024 for the full year 2024. The company provided earnings per share guidance in the range of $5.00 to $5.50, compared to the estimated EPS of $5.16. Additionally, Ligand Pharmaceuticals forecasted revenue between $0.14B and $0.16B for the quarter.
Browse guidance and forecast on all stocks.